Stock search

Ticker or company name

Elevance Health

ELV · NYSE · Health Care

$446,28Up +16,59 (+3,86%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$92,8 bn
Div. yield
1,2%
Year to date
+22,6%
52 weeks: $274,84$450,69

Ratio score

78/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

6 ✓ · 2 — · 1 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM18,117,425,1
Forward P/E14,0—16,2
PEG4,0—2,2
P/S0,50,62,2
EV/EBITDA13,812,917,3
P/FCF13,8—19,5
P/B2,12,83,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 28 analysts

Buy
19
Hold
9
Sell
0

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20264,736,99Up +47,8%
Q2 20266,277,45Up +18,9%
Q1 202610,9312,58Up +15,1%
Q4 20253,133,33Up +6,5%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue51,4 bn50,5 bn50,2 bn49,7 bn50,7 bn49,8 bn48,9 bn45,4 bn45,1 bn43,9 bn42,6 bn42,6 bn
EPS6,276,718,002,545,327,729,611,874,369,859,593,66
Margin2,7%2,9%3,5%1,1%2,3%3,5%4,5%0,9%2,3%5,2%5,3%2,0%
FCF1,00 bn1,63 bn4,10 bn−209 m775 m1,79 bn821 m384 m2,35 bn124 m1,70 bn−3,30 bn

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: purchases $2,24 m (3 people), sales $6,98 m.

NameAmountSharesPrice
lavu ratnakar5 Nov 2026 · sale$572 0001 300$440,00
kaye mark22 Oct 2026 · sale$122 083273$447,19
kaye mark22 Oct 2026 · sale$368 883827$446,05
kaye mark22 Oct 2026 · sale$71 176160$444,85
kaye mark22 Oct 2026 · sale$195 276440$443,81
kaye mark22 Oct 2026 · sale$212 453480$442,61
kaye mark22 Oct 2026 · sale$1,03 m2 343$441,34
kaye mark22 Oct 2026 · sale$757 5571 720$440,44
kaye mark22 Oct 2026 · sale$509 5301 160$439,25
kaye mark22 Oct 2026 · sale$105 173240$438,22
kaye mark22 Oct 2026 · sale$244 759560$437,07
kaye mark22 Oct 2026 · sale$724 0921 660$436,20
kaye mark22 Oct 2026 · sale$139 715321$435,25
kaye mark22 Oct 2026 · sale$173 600400$434,00
boudreaux gail17 Jul 2026 · open-market purchase$753 0712 045$368,25

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
30 Oct 2001

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
HCAHCA Healthcare$511,7869would watch15,4+5,8%8,6%
CICigna$300,1689would consider13,1+6,8%2,3%
CVSCVS Health$88,5983would consider10,4+6,7%2,6%
SYKStryker Corporation$310,7272would consider33,0+7,9%13,8%
CORCencora$356,9483would consider19,7+5,1%0,8%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.